Related Experiment Video
Updated: Jun 25, 2025
06:46
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Published on: January 16, 2013
15.8K
Assessing the causal relationship between immune cells and prostatitis: evidence from bidirectional mendelian
Genyi Qu1, Weimin Jiang1, Zhaohui Long1
1Department of Urology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412007, China.
Summary
This study reveals specific immune cells causally influence prostatitis, while prostatitis also impacts certain immune cells. These findings highlight the bidirectional relationship between immune function and prostatitis for potential targeted therapies.
Area of Science:
- Immunology
- Genetics
- Urology
Background:
- Prostatitis is a prevalent male genitourinary disease with significant health impacts.
- The precise causal role of immune cell activity in prostatitis pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the bidirectional causal relationships between immune cell characteristics and prostatitis.
- To identify specific immune cell types that may influence prostatitis development or progression.
Main Methods:
- Utilized a bidirectional Mendelian randomization (MR) approach with public GWAS data.
- Analyzed 731 immune cell features and their association with prostatitis.
- Employed various MR methods including IVW, MR-Egger, and sensitivity analyses to assess SNP validity and robustness.
Main Results:
- Forward MR identified 17 immune cell features with significant causal effects on prostatitis.
- Reverse MR indicated a significant causal relationship between prostatitis and 13 immune cell features.
- Sensitivity analyses confirmed the stability and reliability of the identified causal links.
Conclusions:
- Established bidirectional causal relationships between specific immune cell phenotypes and prostatitis.
- Suggests a reciprocal interplay between immune system activity and prostatitis.
- Highlights potential for targeted immunomodulatory therapies and the need for diverse population validation.
